Sort   by:  
 Page size 
: Hepatitis B virus (HBV) remains a major public health threat with more than 296 million people chronically infected worldwide at high risk to develop hepatocellular carcinoma. Current therapies are effective in suppressing HBV replication but rarely lead to cure. The fundamental limitation rests o...
ORGANISM(S): Homo sapiens (Human) 
2024-06-16 | PXD042733 | Pride
The combination of peginterferon and ribavirin is the standard treatment for chronic hepatitis C. Our recent clinical study suggests that ribavirin augments the induction of interferon stimulated genes (ISGs) in patients treated for HCV infection [1]. In order to further characterize the mechanism...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size